The effectiveness and cost of exogenous pulmonary surfactant replacement therapy
Date
1995
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Health & Medical Publishing Group
Abstract
The articles"" recently published on surfactant
replacement therapy (SR1) in the treatment of newborn
infants with hyaline membrane disease (HMD) being
ventilated in a country with limited health resources are both
timeous and urgently needed. Surfactant, being an
expensive drug, needs to be administered in the most costeffective
fashion and for this reason research guidelines for
its administration in South Africa are needed. We are
concerned that the discussions of this series of articles do
not sufficiently emphasise their limitations, as well as the
enormous impact of SRT on survival rates and other
neonatal morbidities in newborn infants ventilated with
HMD.
Description
CITATION: Smith, J. Pieper, C. & Gie, R. P. 1995. The effectiveness and cost of exogenous pulmonary surfactant replacement therapy. South African Medical Journal, 85(11):1192-1196.
The original publication is available at http://www.samj.org.za
The original publication is available at http://www.samj.org.za
Keywords
Newborn infants